Cookies?
Library Header Image
LSE Research Online LSE Library Services

Assessing value-for-money in maternal and newborn health

Banke-Thomas, Aduragbemi, Madaj, Barbara, Kumar, Shubha, Ameh, Charles and van den Broek, Nynke (2017) Assessing value-for-money in maternal and newborn health. BMJ Global Health, 2 (2). e000310. ISSN 2059-7908

Full text not available from this repository.
Identification Number: 10.1136/bmjgh-2017-000310

Abstract

Responding to increasing demands to demonstrate value-for-money (VfM) for maternal and newborn health interventions, and in the absence of VfM analysis in peer-reviewed literature, this paper reviews VfM components and methods, critiques their applicability, strengths and weakness and proposes how VfM assessments can be improved. VfM comprises four components: economy, efficiency, effectiveness and cost-effectiveness. Both ‘economy’ and ‘efficiency’ can be assessed with detailed cost analysis utilising costs obtained from programme accounting data or generic cost databases. Before-and-after studies, case–control studies or randomised controlled trials can be used to assess ‘effectiveness’. To assess ‘cost-effectiveness’, cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-benefit analysis (CBA) or social return on investment (SROI) analysis are applicable. Generally, costs can be obtained from programme accounting data or existing generic cost databases. As such ‘economy’ and ‘efficiency’ are relatively easy to assess. However, ‘effectiveness’ and ‘cost-effectiveness’ which require establishment of the counterfactual are more difficult to ascertain. Either a combination of CEA or CUA with tools for assessing other VfM components, or the independent use of CBA or SROI are alternative approaches proposed to strengthen VfM assessments. Cross-cutting themes such as equity, sustainability, scalability and cultural acceptability should also be assessed, as they provide critical contextual information for interpreting VfM assessments. To select an assessment approach, consideration should be given to the purpose, data availability, stakeholders requiring the findings and perspectives of programme beneficiaries. Implementers and researchers should work together to improve the quality of assessments. Standardisation around definitions, methodology and effectiveness measures to be assessed would help.

Item Type: Article
Official URL: http://gh.bmj.com/
Additional Information: © 2017 British Medical Journal © CC BY 4.0
Divisions: Health Policy
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
R Medicine > RJ Pediatrics > RJ101 Child Health. Child health services
Sets: Departments > Health Policy
Date Deposited: 07 Dec 2017 12:28
Last Modified: 24 Mar 2019 00:10
URI: http://eprints.lse.ac.uk/id/eprint/86000

Actions (login required)

View Item View Item